Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

Anti-Aging Medical Group Enters Annual U.S. Quarter Billon Dollar Topical Analgesic Market

Posted on: Tuesday, 4 April 2006, 09:01 CDT

Anti-Aging Medical Group Corp. (OTC: AAGM), a specialty pharmaceutical company focused on developing, acquiring and commercializing innovative and scientifically proven products that offer both health maintenance and appearance enhancing benefits, has signed an agreement with AlphaRx Inc. for the exclusive North American rights to distribute Flexogan. "We are proud to have Anti-Aging Medical Group associated with such an effective and potent pain relief product such as Flexogan, this is the first step of many for our company in achieving our goals on offering products that not only will make you look young but will also help you feel young."

Flexogan is a topical analgesic scientifically formulated to provide fast, effective and long lasting relief from arthritis, joint and muscle pain. The Flexogan brand carries two different products, Flexogan AP and Flexogan MP. These two products make up the Flexogan line that sells in the ever growing topical analgesic market that is estimated to have annual sales of well over $250,000,000 USD in the United States alone.

Anti-Aging Medical Group will be targeting the 34 million Americans who take over-the-counter pain relievers for their arthritis. With an estimated 22 million people diagnosed annually with rheumatoid arthritis and osteoarthritis in the United States, the Company believes that the U.S topical analgesic market has the potential for accelerated growth from its current levels. "We are well positioned to grow with this market, this is a market that is dominated by Pfizers Ben Gay, which captures roughly 20% of the market, but this product I am sure will win many converts once they have tried it, in fact one of our promotional ideas may be to offer samples of Flexogan via our company's website www.anti-agingmedical.net, so stay posted." Rita Sung, President & CEO of the Company.

Flexogan products are non-greasy and fast penetrating, containing Vitamin E and skin protective emollients which leave the skin smooth and free of irritation. Flexogan proprietary colloidal composition utilizes safe, well-known delivery components that are stable, with low-irritancy and high efficacy in the local delivery of biologically active compounds. With a droplet size of less than 40 nanometers and the majority of the oil droplets having a diameter of less than 30 nanometers, colloidal phase separation is reduced thereby dramatically increasing droplet penetration through the epidermis. This enhanced penetration leads to a rapid onset of action (less than 5 minutes), a sensation of deep penetrating warmth at the site of application and a sustained duration of action. As both menthol and camphor have anti-inflammatory properties, the pain relieving effect can last for several hours, even after a relatively small, single application of analgesic cream.

Flexogan AP and MP will be available in 50g and 100g tube.

About Anti-Aging Medical Group

We are a specialty pharmaceutical company focused on developing, acquiring and commercializing innovative and scientifically proven products that offer both health maintenance and appearance enhancing benefits to all of us. We here at Anti-Aging Medical Group call this Nutraceuticals and Cosmeceuticals. Nutraceuticals - are products that have multiple benefits in terms of revitalization for, vision, prostate, bone and joint care as well as memory improvement. At Anti-Aging Medical Group we are developing a drug delivery based, proprietary, non-prescription topical and oral product line which are fast becoming the industry's leader in the treatment of age resistance. Cosmeceuticals - are skin care products which are specifically designed to enhance the appearance of your skin while catering to its needs. Anti-Aging Medical Group is developing a drug delivery based; proprietary skin care product line which fall under our Cosmeceutical's product line. Cosmeceuticals will not only reduce the signs of aging but they also provides significant skin care benefits. They serve enhance skin appearance and reduce signs of aging. For more information about us please visit our website at www.anti-agingmedical.net

This news release contains forward-looking statements. These statements describe management's current beliefs and expectations concerning the future of Anti Aging Medical Group Corp. These forward-looking statements are identified by using words such as "expect,""believe," and "should." Although the beliefs and expectations mentioned in this release are reasonable, the Company's operations involve a number of risks and uncertainties. Therefore, these statements may turn out not to be true. The Company will not update forward-looking statements in this news release to reflect actual results, changes in assumptions, or changes in other factors affecting such forward-looking information.

FORWARD-LOOKING STATEMENTS:

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.

Note: The FDA has not evaluated these statements. This statement is not intended to diagnose, treat, cure of prevent disease.

Distributed by Filing Services Canada and retransmitted by Market Wire

 Contact: Anti-Aging Medical Group Corp. E-mail: Contact via http://www.marketwire.com/mw/emailprcntct?id=5838534C5155BF53  

SOURCE: Anti-Aging Medical Group Corp.


Source: MARKET WIRE

More News in this Category


Related Articles



Rating: 3.1 / 5 (11 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required